Therapeutic Potential of Combined Herbal Medicine and Electroacupuncture in Mild Cognitive Impairment Through Cytokine Modulation: An Observational Study

• Published in: Neuropsychiatric disease and treatment 2024-01, Vol.20, p.1331-1344
• Main Authors: Jang, Jung-Hee, Jun, Hyeong Joon, Lee, ChaYoung, Sohn, Eunjin, Kwon, Ojin, Kang, Dong-Hoon, Umar, Muhammad, Jung, In Chul, Jeong, Soo-Jin
• Format: Article
• Language: English
• Subjects: Acupuncture; Alzheimer's disease; Cognitive ability; Combination therapy; combination treatment; Cytokines; Dementia; Dementia disorders; Development and progression; Disease; Electroacupuncture; Granulocytes; Growth factors; Health aspects; Herbal medicine; Hospitals; inflammation; Intellectual disabilities; Magnetic resonance imaging; Medicine; Medicine, Botanic; Medicine, Herbal; Memory; Mental disorders; Nervous system; Nervous system diseases; network pharmacology; Neurodegenerative diseases; Observational studies; Patient satisfaction; Patients; Performance evaluation; Peripheral nerves; Pharmacology; Proteins; Questionnaires; Traditional medicine; Tumor necrosis factor-TNF
• ISSN: 1176-6328; 1178-2021; 1178-2021
• DOI: 10.2147/NDT.S465650

We aimed to investigate the efficacy of a combined herbal formula and electroacupuncture (EA) for mild cognitive impairment (MCI), a neurodegenerative disease leading to dementia, and its underlying mechanisms of action. This was a prospective open-label observational pilot study at Daejeon Korean Medicine Hospital of Daejeon University in South Korea from March 2022 to March 2023. We included six Korean patients (50% male) aged ≥ 45 years and < 85 years with MCI, a clinical dementia rating score of 0.5, and a Montreal Cognitive Assessment-Korea (MoCA-K) score ≤ 22. The exclusion criterion was impaired cognitive function. Patients received combined therapy, including a herbal formula and EA, for 12-24 weeks. We prescribed the herbal formulas Gamiguibi-tang, Yukmijihwang-tang, and Banhasasim-tang to the patients for at least 70% of the treatment period, in combination with EA. Moreover, we investigated changes in cognitive and cognition-related symptoms and cytokine expression in the blood following combined traditional medicine therapy. At baseline and after 12 and 24 weeks, we administered the MoCA-K and cognitive-related questionnaires. We analyzed network pharmacology to reflect the herbal formula intervention mechanism comprehensively. The median score [interquartile range] of MoCA-K at baseline was 19.5 [16.0, 22.0], which improved significantly (24.5 [24.0, 26.0], < 0.01) over 24 weeks following combined therapy. We obtained no significant conclusion regarding cytokine changes due to the small sample size. In network pharmacology, we analyzed the brain, head, heart, peripheral nerves, peripheral nervous system, and pancreas as the enriched organs from the common targets of the three herbal formulas. Combined herbal medicine and EA improved cognitive function in patients with MCI. We assume the underlying mechanism of herbal formulas to be antioxidative and anti-inflammatory changes in cytokine expression. Combined traditional medicine has potential therapeutic application in preventing MCI progression to dementia.